<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7755418</article-id>
    <article-id pub-id-type="pmid">32756939</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa618</article-id>
    <article-id pub-id-type="publisher-id">btaa618</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Papers</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IDRMutPred: predicting disease-associated germline nonsynonymous single nucleotide variants (nsSNVs) in intrinsically disordered regions</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zhou</surname>
          <given-names>Jing-Bo</given-names>
        </name>
        <aff>
          <institution>Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China</institution>
        </aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4169-4040</contrib-id>
        <name>
          <surname>Xiong</surname>
          <given-names>Yao</given-names>
        </name>
        <aff>
          <institution>Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China</institution>
        </aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>An</surname>
          <given-names>Ke</given-names>
        </name>
        <aff>
          <institution>Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China</institution>
        </aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8822-6148</contrib-id>
        <name>
          <surname>Ye</surname>
          <given-names>Zhi-Qiang</given-names>
        </name>
        <xref rid="btaa618-cor1" ref-type="corresp"/>
        <aff>
          <institution>Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China</institution>
        </aff>
        <aff><institution>Shenzhen Bay Laboratory</institution>, Shenzhen 518055, <country country="CN">China</country></aff>
        <!--yezq@pku.org.cn-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Wu</surname>
          <given-names>Yun-Dong</given-names>
        </name>
        <xref rid="btaa618-cor1" ref-type="corresp"/>
        <aff>
          <institution>Lab of Computational Chemistry and Drug Design, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China</institution>
        </aff>
        <aff><institution>Shenzhen Bay Laboratory</institution>, Shenzhen 518055, <country country="CN">China</country></aff>
        <aff><institution>College of Chemistry and Molecular Engineering, Peking University</institution>, Beijing 100871, <country country="CN">China</country></aff>
        <!--ydwu@pku.edu.cn-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Luigi Martelli</surname>
          <given-names>Pier</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btaa618-cor1">To whom correspondence should be addressed. <email>yezq@pku.org.cn</email> or <email>ydwu@pku.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>10</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-08-05">
      <day>05</day>
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>05</day>
      <month>8</month>
      <year>2020</year>
    </pub-date>
    <volume>36</volume>
    <issue>20</issue>
    <fpage>4977</fpage>
    <lpage>4983</lpage>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>10</month>
        <year>2019</year>
      </date>
      <date date-type="rev-recd">
        <day>28</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>01</day>
        <month>7</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa618.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Despite of the lack of folded structure, intrinsically disordered regions (IDRs) of proteins play versatile roles in various biological processes, and many nonsynonymous single nucleotide variants (nsSNVs) in IDRs are associated with human diseases. The continuous accumulation of nsSNVs resulted from the wide application of NGS has driven the development of disease-association prediction methods for decades. However, their performance on nsSNVs in IDRs remains inferior, possibly due to the domination of nsSNVs from structured regions in training data. Therefore, it is highly demanding to build a disease-association predictor specifically for nsSNVs in IDRs with better performance.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We present IDRMutPred, a machine learning-based tool specifically for predicting disease-associated germline nsSNVs in IDRs. Based on 17 selected optimal features that are extracted from sequence alignments, protein annotations, hydrophobicity indices and disorder scores, IDRMutPred was trained using three ensemble learning algorithms on the training dataset containing only IDR nsSNVs. The evaluation on the two testing datasets shows that all the three prediction models outperform 17 other popular general predictors significantly, achieving the ACC between 0.856 and 0.868 and MCC between 0.713 and 0.737. IDRMutPred will prioritize disease-associated IDR germline nsSNVs more reliably than general predictors.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The software is freely available at <ext-link xlink:href="http://www.wdspdb.com/IDRMutPred" ext-link-type="uri">http://www.wdspdb.com/IDRMutPred</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>31471243</award-id>
        <award-id>21933004</award-id>
        <award-id>30800641</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shenzhen Science and Technology Innovation Commission</institution>
            <institution-id institution-id-type="DOI">10.13039/501100010877</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>JCYJ20170818085409785</award-id>
        <award-id>JCYJ20170412150507046</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Program for Guangdong Introducing Innovative and Entrepreneurial Talents</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Shenzhen Municipal Health Commission</institution>
          </institution-wrap>
        </funding-source>
        <award-id>SZSM201809085</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="7"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>The paradigm of âsequence-structure-functionâ states that the protein sequence will fold into well-defined domain structure, and the folded structure will then fulfill specific function (<xref rid="btaa618-B13" ref-type="bibr">Edsall, 1995</xref>). This well-established dogma has been dominant in structural biology and has led to great successes in revealing the structural basis of numerous fundamental biological processes, including oxygen transport of hemoglobin (<xref rid="btaa618-B34" ref-type="bibr">Marengo-Rowe, 2006</xref>), protein translation of ribosome machine (<xref rid="btaa618-B54" ref-type="bibr">Schmeing and Ramakrishnan, 2009</xref>), enzymatic catalysis and so on. It has also played a vital part in understanding the disease mechanisms of genetic variants (<xref rid="btaa618-B56" ref-type="bibr">Stefl <italic toggle="yes">et al.</italic>, 2013</xref>), and in structure-based drug discovery (<xref rid="btaa618-B2" ref-type="bibr">Anderson, 2003</xref>). On the other hand, a large fraction of protein segments, enriched with hydrophilic and charged residues, lack stable structures (<xref rid="btaa618-B3" ref-type="bibr">Babu <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btaa618-B29" ref-type="bibr">Lise and Jones, 2004</xref>; <xref rid="btaa618-B52" ref-type="bibr">Romero <italic toggle="yes">et al.</italic>, 2001</xref>; <xref rid="btaa618-B64" ref-type="bibr">Uversky <italic toggle="yes">et al.</italic>, 2000</xref>). These segments are named intrinsically disordered regions (IDRs), and a large percentage of human proteins (35â44% due to different predictors and statistic methods) contain IDRs longer than 30 residues (<xref rid="btaa618-B44" ref-type="bibr">Pentony <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btaa618-B68" ref-type="bibr">Van Der Lee <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btaa618-B71" ref-type="bibr">Ward <italic toggle="yes">et al.</italic>, 2004</xref>). Previously regarded as âuselessâ, IDRs have been confirmed to have versatile regulatory functions by acting as entropic chains, effectors, scavengers, assemblers, chaperones and display sites (<xref rid="btaa618-B60" ref-type="bibr">Tompa, 2002</xref>, <xref rid="btaa618-B61" ref-type="bibr">2005</xref>; <xref rid="btaa618-B68" ref-type="bibr">Van Der Lee <italic toggle="yes">et al.</italic>, 2014</xref>). Malfunctioning of IDRs is associated with a broad spectrum of human diseases, such as cancers (<xref rid="btaa618-B22" ref-type="bibr">Iakoucheva <italic toggle="yes">et al.</italic>, 2002</xref>; <xref rid="btaa618-B63" ref-type="bibr">Uversky <italic toggle="yes">et al.</italic>, 2014</xref>), cardiovascular diseases (<xref rid="btaa618-B8" ref-type="bibr">Cheng <italic toggle="yes">et al.</italic>, 2006</xref>), neurodegenerative diseases (<xref rid="btaa618-B48" ref-type="bibr">Raychaudhuri <italic toggle="yes">et al.</italic>, 2009</xref>) and type 2 diabetes (<xref rid="btaa618-B65" ref-type="bibr">Uversky <italic toggle="yes">et al.</italic>, 2008</xref>), and computational strategies for rational drug discovery that targets IDR are also emerging (<xref rid="btaa618-B53" ref-type="bibr">Ruan <italic toggle="yes">et al.</italic>, 2019</xref>). Overall, it was estimated that a substantial portion (â¼20%) of pathogenic nonsynonymous single nucleotide variants (nsSNVs) are located in IDRs (<xref rid="btaa618-B67" ref-type="bibr">Vacic <italic toggle="yes">et al.</italic>, 2012</xref>). For example, variant R306C in MECP2 leads to Rett syndrome (<xref rid="btaa618-B66" ref-type="bibr">Vacic and Iakoucheva, 2012</xref>), a host of variants in BRCA1 promote the development of breast cancer (<xref rid="btaa618-B35" ref-type="bibr">Mark <italic toggle="yes">et al.</italic>, 2005</xref>) and the dileucine motif gain by variants in GLUT1 causes the GLUT1 deficiency syndrome (<xref rid="btaa618-B36" ref-type="bibr">Meyer <italic toggle="yes">et al.</italic>, 2018</xref>). Hence, studies on disease variants located at IDRs are as crucial as those in structured domains.</p>
    <p>Recent years have witnessed the unprecedented advances in next-generation sequencing techniques, and their wide applications in disease research such as whole exome sequencing have generated a huge amount of variant data (<xref rid="btaa618-B17" ref-type="bibr">Goodwin <italic toggle="yes">et al.</italic>, 2016</xref>). Since the identified variants contain both disease-associated and non-disease (neutral) ones, the major challenge is to discriminate them in a high throughput manner (<xref rid="btaa618-B10" ref-type="bibr">Cooper and Shendure, 2011</xref>). While the experimental approaches are labor intensive and time consuming, a multitude of computational predictors have been developed, whose results can largely narrow down the variants pool for further experimental validation (<xref rid="btaa618-B41" ref-type="bibr">Niroula and Vihinen, 2016</xref>).</p>
    <p>Significant progress has been made in developing tools to predict disease-associated nsSNVs (<xref rid="btaa618-B51" ref-type="bibr">Riera <italic toggle="yes">et al.</italic>, 2014</xref>). Most of them are trained on variants from diverse protein families, and are thus general-purpose predictors. Among them, conservation and structural stability features have been used most widely (<xref rid="btaa618-B51" ref-type="bibr">Riera <italic toggle="yes">et al.</italic>, 2014</xref>). However, the broadly distributed IDRs have neither ordered structures, nor are they as conserved as ordered regions (ORs) (<xref rid="btaa618-B5" ref-type="bibr">Brown <italic toggle="yes">et al.</italic>, 2011</xref>), raising the concern that the disease-association prediction of variants in IDRs using general tools is supposed to be inferior. In fact, previous research observed that general predictors like SIFT encountered more misclassification on disease-associated nsSNVs in IDRs (<xref rid="btaa618-B37" ref-type="bibr">Mort <italic toggle="yes">et al.</italic>, 2010</xref>). Several studies have reported that the amount, the distribution and other characteristics of IDR variants (<xref rid="btaa618-B65" ref-type="bibr">Uversky <italic toggle="yes">et al.</italic>, 2008</xref>, <xref rid="btaa618-B63" ref-type="bibr">2014</xref>; <xref rid="btaa618-B67" ref-type="bibr">Vacic <italic toggle="yes">et al.</italic>, 2012</xref>), but there is currently no disease-association predictors for them. Considering the indispensable roles played by IDRs in function regulation and pathogenesis, and that the widely used sequencing technologies are continuing to generate a huge amount of variants in IDRs, it is highly desirable to build a disease-association predictor specifically for IDR variants.</p>
    <p>In this work, we have developed a machine learning-based disease-association predictor specifically for germline nsSNVs in IDRs (<xref rid="btaa618-F1" ref-type="fig">Fig.Â 1</xref>). First, a training and two testing datasets containing germline variants from IDRs was curated. Second, we extracted 175 features, and selected 17 optimal ones through feature selection. Third, three tree-based ensemble machine learning algorithms were adopted to train prediction models, and the comparison with other general prediction tools was conducted. Finally, a standalone package and its web server, namely IDRMutPred, was developed.
</p>
    <fig position="float" id="btaa618-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>The pipeline of building the IDR disease nsSNV predictor. DVs and NVs represent disease-associated and neutral nsSNVs, respectively</p>
      </caption>
      <graphic xlink:href="btaa618f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>The overall pipeline of our work is illustrated in <xref rid="btaa618-F1" ref-type="fig">FigureÂ 1</xref>, and is described as follows.</p>
    <sec>
      <title>2.1 Datasets curation</title>
      <p>Human protein sequences were derived from UniProt/Swiss-Prot database (Release 2019_01 of January 16, 2019) (<xref rid="btaa618-B59" ref-type="bibr">The UniProt Consortium, 2019</xref>), and the germline nsSNVs were parsed accordingly from the file âhumsavar.txtâ from the UniProt FTP server. The nsSNVs labeled with âDiseaseâ and âPolymorphismâ, representing variants reported to be implicated in disease or not, were regarded as positive and negative samples, respectively.</p>
      <p>We regarded that a residue is located in IDR if it was experimentally annotated in DisProt (Release 7) database (<xref rid="btaa618-B46" ref-type="bibr">Piovesan <italic toggle="yes">et al.</italic>, 2017</xref>) or could be predicted as disordered by SPOT-Disorder (<xref rid="btaa618-B19" ref-type="bibr">Hanson <italic toggle="yes">et al.</italic>, 2016</xref>). By screening out the nsSNVs located outside IDRs, we obtained the IDR nsSNV dataset. Random sampling was utilized to build a balanced dataset. About one-tenth of the dataset was kept for independent testing, while the remaining served as the training dataset for feature selection and model training. Another third-party dataset for further evaluation was based on ToolScores datasets (<xref rid="btaa618-B18" ref-type="bibr">Grimm <italic toggle="yes">et al.</italic>, 2015</xref>) from VariBench (<xref rid="btaa618-B38" ref-type="bibr">Nair and Vihinen, 2013</xref>). After aggregating its five member datasets, we deleted the nsSNVs with conflicting class labels, kept only one occurrence for duplicates with consistent class labels, and retained the IDR nsSNVs. The third-party dataset was then constructed by removing those that have occurred in the training set and selecting equal number of positive and negative samples.</p>
    </sec>
    <sec>
      <title>2.2 Feature extraction</title>
      <p>A total of 175 features were calculated for each of the IDR nsSNVs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>), and were subjected to further feature selection. These features can be categorized into 5 groups, including 2 substitution matrix scores, 152 sequence alignment features, 6 amino acid hydrophobicity scores, 9 protein-/gene-level annotations and 6 disorder scores, all feature values in the training data were standardized (<xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>). Feature values in the independent testing and the third-party dataset were transformed accordingly with the parameters derived during the standardization of training data.</p>
    </sec>
    <sec>
      <title>2.3 Feature selection</title>
      <p>Feature selection is a necessary part in machine learning because the initial feature set often contain unnecessary, irrelevant and redundant features, which may slow down the training procedure or introduce over-fitting (<xref rid="btaa618-B12" ref-type="bibr">Drotar <italic toggle="yes">et al.</italic>, 2015</xref>). In this work, we implemented a feature selection strategy by combining forward selection and backward elimination, which wrapped a machine learning algorithm as the backend engine for evaluating the goodness of the feature subsets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>).</p>
    </sec>
    <sec>
      <title>2.4 Prediction model training</title>
      <p>We attempted three tree-based machine learning algorithms, including random forest (RF) (<xref rid="btaa618-B4" ref-type="bibr">Breiman, 2001</xref>), extreme gradient boosting (XGBoost) (<xref rid="btaa618-B7" ref-type="bibr">Chen and Guestrin, 2016</xref>) and light gradient boosting machine (LightGBM) (<xref rid="btaa618-B28" ref-type="bibr">Ke <italic toggle="yes">et al.</italic>, 2017</xref>). RF is a classic machine learning framework by constructing a multitude of decision trees in parallel, while XGBoost and LightGBM are two more modern ones by constructing gradient boosting trees. Remarkably, LightGBM has faster training speed and lower memory usage (<xref rid="btaa618-B28" ref-type="bibr">Ke <italic toggle="yes">et al.</italic>, 2017</xref>).</p>
      <p>For each algorithm, we randomly tried a series of hyperparameter combinations (random search), and we chose the one with the best AUC in the G10FCV (described in Section 2.5). After obtaining the best hyperparameter combination, we trained the final prediction models using all the training data accordingly. The feature importance was outputted to compare the relative contributions between different features, and MannâWhitney <italic toggle="yes">U</italic> test was performed when comparing each feature between disease and neutral nsSNVs. The python packages including scikit-learn v0.20.1 (<xref rid="btaa618-B42" ref-type="bibr">Pedregosa <italic toggle="yes">et al.</italic>, 2011</xref>), xgboost v0.82 and lightgbm v2.2.1 were adopted in our work.</p>
    </sec>
    <sec>
      <title>2.5 Cross-validation and performance evaluation</title>
      <p>Tenfold cross-validation was utilized for finding the best hyperparameter combination. In the separation of data into 10 parts, we required that nsSNVs from the same protein would not be split into different data parts, i.e. the nsSNVs were split at the protein level. Technically, we implemented this process using the Python module GroupKFold in scikit-learn package (<xref rid="btaa618-B42" ref-type="bibr">Pedregosa <italic toggle="yes">et al.</italic>, 2011</xref>), and it was referred to as grouped 10-fold cross-validation (G10FCV). Given a hyperparameter combination, the average performance obtained by G10FCV was adopted to measure the goodness of this hyperparameter combination. By trying various combinations of hyperparameters, one can select the optimal one.</p>
      <p>We adopted four comprehensive performance metrics, including accuracy (ACC), Matthewâs Correlation Coefficient (MCC), F1 score and area under the receiver operating characteristic curve (AUC). The detailed definitions are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>.</p>
      <p>Using the testing datasets, we compared the performance of our models with 17 popular general predictors, including SIFT (<xref rid="btaa618-B39" ref-type="bibr">Ng and Henikoff, 2001</xref>), PolyPhen2 (<xref rid="btaa618-B1" ref-type="bibr">Adzhubei <italic toggle="yes">et al.</italic>, 2010</xref>), PhD-SNP (<xref rid="btaa618-B6" ref-type="bibr">Capriotti <italic toggle="yes">et al.</italic>, 2006</xref>), MutationAssessor (<xref rid="btaa618-B50" ref-type="bibr">Reva <italic toggle="yes">et al.</italic>, 2011</xref>), FATHMM (<xref rid="btaa618-B55" ref-type="bibr">Shihab <italic toggle="yes">et al.</italic>, 2013</xref>), PON-P2 (<xref rid="btaa618-B40" ref-type="bibr">Niroula <italic toggle="yes">et al.</italic>, 2015</xref>), PROVEAN (<xref rid="btaa618-B9" ref-type="bibr">Choi and Chan, 2015</xref>), PANTHER-PSEP (<xref rid="btaa618-B57" ref-type="bibr">Tang and Thomas, 2016a</xref>), Eigen (<xref rid="btaa618-B24" ref-type="bibr">Ionita-Laza <italic toggle="yes">et al.</italic>, 2016</xref>), REVEL (<xref rid="btaa618-B23" ref-type="bibr">Ioannidis <italic toggle="yes">et al.</italic>, 2016</xref>), PMut2017 (<xref rid="btaa618-B31" ref-type="bibr">Lopez-Ferrando <italic toggle="yes">et al.</italic>, 2017</xref>), MutPred2 (<xref rid="btaa618-B43" ref-type="bibr">Pejaver <italic toggle="yes">et al.</italic>, 2017</xref>), CADD (<xref rid="btaa618-B49" ref-type="bibr">Rentzsch <italic toggle="yes">et al.</italic>, 2019</xref>), LIST (<xref rid="btaa618-B33" ref-type="bibr">Malhis <italic toggle="yes">et al.</italic>, 2019</xref>), MetaSVM (<xref rid="btaa618-B11" ref-type="bibr">Dong <italic toggle="yes">et al.</italic>, 2015</xref>), MetaLR (<xref rid="btaa618-B11" ref-type="bibr">Dong <italic toggle="yes">et al.</italic>, 2015</xref>) and M-CAP (<xref rid="btaa618-B27" ref-type="bibr">Jagadeesh <italic toggle="yes">et al.</italic>, 2016</xref>). Among them, two versions of PolyPhen2 (pph2-HumDiv and pph2-HumVar) and FATHMM (weighted fathmm-W and unweighted fathmm-U) were both adopted in the comparison. The prediction results of PolyPhen2, MutationAssessor, PON-P2, PMut2017 and LIST were obtained using their web servers, and those of Eigen, REVEL, CADD, metaSVM/metaLR and M-CAP were downloaded from dbNSFP v3.5a (<xref rid="btaa618-B30" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2016</xref>). The prediction results of all other predictors were obtained by running their standalone programs with default settings locally.</p>
    </sec>
    <sec>
      <title>2.6 Implementation of the predictor</title>
      <p>To ease the application of our models, we implemented a standalone package to automate the whole process. Based on Python 3.6.6, a set of modules were implemented to calculate all necessary features. By feeding them into the trained models, this package can make predictions in high throughput.</p>
      <p>A web server was built to further facilitate the researchers without bioinformatics skills. The Django (v2.1.0) (<ext-link xlink:href="https://www.djangoproject.com/" ext-link-type="uri">https://www.djangoproject.com/</ext-link>) and Bootstrap library (v3.3.7) (<ext-link xlink:href="https://getbootstrap.com/" ext-link-type="uri">https://getbootstrap.com/</ext-link>) were utilized to construct the web framework, MySQL (<ext-link xlink:href="https://www.mysql.com/" ext-link-type="uri">https://www.mysql.com/</ext-link>) database management system was adopted to temporarily store the prediction results and to manage the submitted job queue, and Apache httpd (<ext-link xlink:href="https://httpd.apache.org" ext-link-type="uri">https://httpd.apache.org</ext-link>) was chosen to provide the web services.</p>
    </sec>
  </sec>
  <sec>
    <title>3 Results</title>
    <sec>
      <title>3.1 Construction of the training and testing datasets</title>
      <p>In total, 29Â 544 disease and 39Â 801 neutral nsSNVs located in 12Â 518 human proteins were derived from humsavar.txt provided by UniProt/Swiss-Prot (<xref rid="btaa618-B59" ref-type="bibr">The UniProt Consortium, 2019</xref>), and 78Â 732 IDRs were obtained. The integration of nsSNV and IDR resulted in 2793 disease-associated and 12Â 980 neutral nsSNVs located in IDRs from 6337 proteins (<xref rid="btaa618-F1" ref-type="fig">Fig.Â 1</xref>).</p>
      <p>A total of 2793 neutral nsSNVs were randomly sampled and were combined with the 2793 disease nsSNVs to build a balanced dataset. From it, 297 disease nsSNVs and 262 neutral nsSNVs (â¼1/10 of the balanced dataset) were randomly chosen for independent testing, while the remaining were kept for training (<xref rid="btaa618-T1" ref-type="table">TableÂ 1</xref>). We required that all nsSNVs from the same protein were either in the testing set or in the training set.
</p>
      <table-wrap position="float" id="btaa618-T1">
        <label>Table 1</label>
        <caption>
          <p>Summary of the training and testing datasets</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">Dataset</th>
              <th rowspan="1" colspan="1">Number of disease nsSNVs</th>
              <th rowspan="1" colspan="1">Number of neutral nsSNVs</th>
              <th rowspan="1" colspan="1">Number of IDRs</th>
              <th rowspan="1" colspan="1">Number of proteins</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Training</td>
              <td rowspan="1" colspan="1">2496</td>
              <td rowspan="1" colspan="1">2531</td>
              <td rowspan="1" colspan="1">2821</td>
              <td rowspan="1" colspan="1">2390</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Independent testing</td>
              <td rowspan="1" colspan="1">297</td>
              <td rowspan="1" colspan="1">262</td>
              <td rowspan="1" colspan="1">313</td>
              <td rowspan="1" colspan="1">262</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Third-party testing</td>
              <td rowspan="1" colspan="1">2897</td>
              <td rowspan="1" colspan="1">2897</td>
              <td rowspan="1" colspan="1">2914</td>
              <td rowspan="1" colspan="1">2562</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The ToolScores datasets from VariBench database contain 4597 disease-associated and 11Â 328 neutral nsSNVs in IDRs (<xref rid="btaa618-B18" ref-type="bibr">Grimm <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btaa618-B38" ref-type="bibr">Nair and Vihinen, 2013</xref>). After removing nsSNVs that have occurred in the training dataset, we randomly sampled 2897 neutral nsSNVs to combine with the 2897 disease-associated ones, serving as a third-party testing dataset for further evaluation (<xref rid="btaa618-T1" ref-type="table">TableÂ 1</xref>).</p>
    </sec>
    <sec>
      <title>3.2 Optimal feature subset</title>
      <p>Our feature selection strategy is involved with a huge number of training iterations on various feature combinations, so the computational cost is demanding. Due to its speediness, we adopted LightGBM (<xref rid="btaa618-B28" ref-type="bibr">Ke <italic toggle="yes">et al.</italic>, 2017</xref>) as the backend engine of feature selection. The procedure of feature selection on all of the 175 candidates resulted in an optimal feature subset with 17 features, including 9 sequence alignment features, 4 protein-/gene-level annotations, 3 hydrophobicity features and 1 disorder feature (<xref rid="btaa618-T2" ref-type="table">TableÂ 2</xref>). The detailed feature definitions are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>. In the alignment features, four of them are related to the frequencies of wild-type and mutant residues (#2, #3, #6, #7 in <xref rid="btaa618-T2" ref-type="table">TableÂ 2</xref>) in the forms of proportion or number of wild-type or mutant residues, or position weight matrix score; three directly describe the conservation of the nsSNV site in terms of relative entropy (#4, #8, #9); two represent the quality of the alignment (#1, #5). The selected gene-/protein-level features measure the variation tolerance (#12, #13), essentiality (#14) and recessive disease-association probability (#11) of the gene that bears the nsSNV. Other selected features measure the hydrophobicity of the microenvironment around the nsSNV site (#15, #17), the hydrophobicity difference between wild-type and mutant residues (#16), and the disorder level at the nsSNV site (#10).
</p>
      <table-wrap position="float" id="btaa618-T2">
        <label>Table 2</label>
        <caption>
          <p>The 17 selected optimal features</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="left" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="1" colspan="1">#</th>
              <th align="left" rowspan="1" colspan="1">Feature name</th>
              <th align="left" rowspan="1" colspan="1">Description</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">b9_eva_nal_w</td>
              <td rowspan="1" colspan="1">Weighted number of sequences in the alignment based on BLAST against UniRef90 with E-value of 10E-45</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">b9_all_rwt</td>
              <td rowspan="1" colspan="1">Proportion of wild-type residue at the nsSNV site in the alignment (UniRef90, E-value: default)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">b9_eva_rmt_w</td>
              <td rowspan="1" colspan="1">Weighted proportion of mutant residue at the nsSNV site in the alignment (UniRef90, E-value: 10E-45)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">4</td>
              <td rowspan="1" colspan="1">b9_eva_ree</td>
              <td rowspan="1" colspan="1">Relative entropy based on the alignment (UniRef90, E-value: 10E-45)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">5</td>
              <td rowspan="1" colspan="1">b1_eva_naa_w</td>
              <td rowspan="1" colspan="1">Weighted number of residues at the nsSNV site in the alignment (UniRef100, E-value: 10E-75)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">6</td>
              <td rowspan="1" colspan="1">b1_hum_nmt_w</td>
              <td rowspan="1" colspan="1">Weighted number of mutant residues at the nsSNV site in the alignment (UniRef100 human, E-value: default)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">7</td>
              <td rowspan="1" colspan="1">b1_nhu_pwm_w</td>
              <td rowspan="1" colspan="1">Weighted position weight matrix score based on the alignment (UniRef100 non-human, E-value: default)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">8</td>
              <td rowspan="1" colspan="1">b1_hum_ree</td>
              <td rowspan="1" colspan="1">Relative entropy based on the alignment (UniRef100 human, E-value: default)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">9</td>
              <td rowspan="1" colspan="1">b1_nhu_ree</td>
              <td rowspan="1" colspan="1">Relative entropy based on the alignment (UniRef100 non-human, E-value: default)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">10</td>
              <td rowspan="1" colspan="1">pos_spo</td>
              <td rowspan="1" colspan="1">SPOT-Disorder score of the wild-type residue at the nsSNV site (<xref rid="btaa618-B19" ref-type="bibr">Hanson <italic toggle="yes">et al.</italic>, 2016</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">11</td>
              <td rowspan="1" colspan="1">pro_Prec</td>
              <td rowspan="1" colspan="1">Estimated probability that a gene is a recessive disease gene (<xref rid="btaa618-B32" ref-type="bibr">MacArthur <italic toggle="yes">et al.</italic>, 2012</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">12</td>
              <td rowspan="1" colspan="1">pro_RVIS_ExAC</td>
              <td rowspan="1" colspan="1">ExAC-based RVIS score (<xref rid="btaa618-B45" ref-type="bibr">Petrovski <italic toggle="yes">et al.</italic>, 2013</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">13</td>
              <td rowspan="1" colspan="1">pro_GDI_Phred</td>
              <td rowspan="1" colspan="1">Phred-scaled GDI score (<xref rid="btaa618-B25" ref-type="bibr">Itan <italic toggle="yes">et al.</italic>, 2015</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">14</td>
              <td rowspan="1" colspan="1">pro_Essential_gene</td>
              <td rowspan="1" colspan="1">Gene essentiality (<xref rid="btaa618-B16" ref-type="bibr">Georgi <italic toggle="yes">et al.</italic>, 2013</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">15</td>
              <td rowspan="1" colspan="1">hww_9</td>
              <td rowspan="1" colspan="1">Sum of WimleyâWhite hydropathy index of neighboring residues with a window of 9 (<xref rid="btaa618-B72" ref-type="bibr">Wimley and White, 1996</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">16</td>
              <td rowspan="1" colspan="1">hwo_d</td>
              <td rowspan="1" colspan="1">Difference of octanolâwater free energy transfer index (<xref rid="btaa618-B14" ref-type="bibr">Eisenberg and McLachlan, 1986</xref>)</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">17</td>
              <td rowspan="1" colspan="1">hwo_3</td>
              <td rowspan="1" colspan="1">Sum of octanolâwater free energy transfer index of neighboring residues with a window of 3</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec>
      <title>3.3 Prediction model training and evaluation</title>
      <p>Based on G10FCV on the training dataset with the optimal features, we determined the best hyperparameter combination from 1000 randomly generated ones using RF, XGBoost and LightGBM, respectively. The best hyperparameters and the performance metrics of cross-validation are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S2 and S3</xref>. Using these best hyperparameters accordingly, the model parameters of the three prediction models were trained on the whole training dataset. Notably, our cross-validation is based on splitting nsSNVs at the protein level, which has avoided the so-called type 2 circularity (<xref rid="btaa618-B18" ref-type="bibr">Grimm <italic toggle="yes">et al.</italic>, 2015</xref>). This strategy will decrease the risk of overly fitting the prediction models to protein-/gene-level features.</p>
      <p>Using the independent testing dataset, we directly compared the performance of our models with 14 of the 17 general-purpose predictors (<xref rid="btaa618-T3" ref-type="table">TableÂ 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>). The comparison shows that our models rank on the top tier for all of the four-performance metrics. In detail, our best ACC (0.868), MCC (0.737), F1 score (0.872) and AUC (0.934) have improved 3.3, 4.1, 1.2 and 0.5 percentage point, respectively, when compared to the best one in the other 13 predictors. The most significant improvement comes from MCC, a robust performance metric that balances positive and negative predictions.
</p>
      <table-wrap position="float" id="btaa618-T3">
        <label>Table 3</label>
        <caption>
          <p>Performance comparison on the independent testing dataset and third-party testing dataset</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col valign="top" align="left" span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
            <col valign="top" align="char" char="." span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th rowspan="2" colspan="1">Method<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></th>
              <th colspan="4" rowspan="1">Independent testing dataset<hr/></th>
              <th colspan="4" rowspan="1">Third-party dataset<hr/></th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">ACC</th>
              <th rowspan="1" colspan="1">MCC</th>
              <th rowspan="1" colspan="1">F1 score</th>
              <th rowspan="1" colspan="1">AUC</th>
              <th rowspan="1" colspan="1">ACC</th>
              <th rowspan="1" colspan="1">MCC</th>
              <th rowspan="1" colspan="1">F1 score</th>
              <th rowspan="1" colspan="1">AUC</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="9" rowspan="1">Predictors without protein-/gene-level features</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âSIFT</td>
              <td rowspan="1" colspan="1">0.793</td>
              <td rowspan="1" colspan="1">0.584</td>
              <td rowspan="1" colspan="1">0.803</td>
              <td rowspan="1" colspan="1">0.863</td>
              <td rowspan="1" colspan="1">0.660</td>
              <td rowspan="1" colspan="1">0.321</td>
              <td rowspan="1" colspan="1">0.642</td>
              <td rowspan="1" colspan="1">0.723</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âpph2-HumDiv</td>
              <td rowspan="1" colspan="1">0.773</td>
              <td rowspan="1" colspan="1">0.542</td>
              <td rowspan="1" colspan="1">0.791</td>
              <td rowspan="1" colspan="1">0.854</td>
              <td rowspan="1" colspan="1">0.637</td>
              <td rowspan="1" colspan="1">0.279</td>
              <td rowspan="1" colspan="1">0.611</td>
              <td rowspan="1" colspan="1">0.693</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âpph2-HumVar</td>
              <td rowspan="1" colspan="1">0.782</td>
              <td rowspan="1" colspan="1">0.572</td>
              <td rowspan="1" colspan="1">0.781</td>
              <td rowspan="1" colspan="1">0.872</td>
              <td rowspan="1" colspan="1">0.666</td>
              <td rowspan="1" colspan="1">0.353</td>
              <td rowspan="1" colspan="1">0.604</td>
              <td rowspan="1" colspan="1">0.745</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âPhD-SNP</td>
              <td rowspan="1" colspan="1">0.816</td>
              <td rowspan="1" colspan="1">0.664</td>
              <td rowspan="1" colspan="1">0.799</td>
              <td rowspan="1" colspan="1">â<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref></td>
              <td rowspan="1" colspan="1">0.673</td>
              <td rowspan="1" colspan="1">0.412</td>
              <td rowspan="1" colspan="1">0.552</td>
              <td rowspan="1" colspan="1">â<xref rid="tblfn2" ref-type="table-fn"><sup>b</sup></xref></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âMutationAssessor</td>
              <td rowspan="1" colspan="1">0.773</td>
              <td rowspan="1" colspan="1">0.559</td>
              <td rowspan="1" colspan="1">0.770</td>
              <td rowspan="1" colspan="1">0.856</td>
              <td rowspan="1" colspan="1">0.663</td>
              <td rowspan="1" colspan="1">0.341</td>
              <td rowspan="1" colspan="1">0.614</td>
              <td rowspan="1" colspan="1">0.755</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âfathmm-U</td>
              <td rowspan="1" colspan="1">0.753</td>
              <td rowspan="1" colspan="1">0.518</td>
              <td rowspan="1" colspan="1">0.745</td>
              <td rowspan="1" colspan="1">0.831</td>
              <td rowspan="1" colspan="1">0.615</td>
              <td rowspan="1" colspan="1">0.252</td>
              <td rowspan="1" colspan="1">0.514</td>
              <td rowspan="1" colspan="1">0.665</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âPROVEAN</td>
              <td rowspan="1" colspan="1">0.785</td>
              <td rowspan="1" colspan="1">0.590</td>
              <td rowspan="1" colspan="1">0.774</td>
              <td rowspan="1" colspan="1">0.862</td>
              <td rowspan="1" colspan="1">0.636</td>
              <td rowspan="1" colspan="1">0.310</td>
              <td rowspan="1" colspan="1">0.522</td>
              <td rowspan="1" colspan="1">0.675</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âPANTHER-PSEP</td>
              <td rowspan="1" colspan="1">0.805</td>
              <td rowspan="1" colspan="1">0.598</td>
              <td rowspan="1" colspan="1">0.845</td>
              <td rowspan="1" colspan="1">0.858</td>
              <td rowspan="1" colspan="1">0.527</td>
              <td rowspan="1" colspan="1">0.068</td>
              <td rowspan="1" colspan="1">0.496</td>
              <td rowspan="1" colspan="1">0.649</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âEigen</td>
              <td rowspan="1" colspan="1">0.801</td>
              <td rowspan="1" colspan="1">0.556</td>
              <td rowspan="1" colspan="1">0.707</td>
              <td rowspan="1" colspan="1">0.840</td>
              <td rowspan="1" colspan="1">0.671</td>
              <td rowspan="1" colspan="1">0.357</td>
              <td rowspan="1" colspan="1">0.610</td>
              <td rowspan="1" colspan="1">0.735</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âPMut2017</td>
              <td rowspan="1" colspan="1">0.834</td>
              <td rowspan="1" colspan="1">0.696</td>
              <td rowspan="1" colspan="1">0.826</td>
              <td rowspan="1" colspan="1">0.924</td>
              <td rowspan="1" colspan="1">0.772</td>
              <td rowspan="1" colspan="1">0.365</td>
              <td rowspan="1" colspan="1">0.452</td>
              <td rowspan="1" colspan="1">0.765</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âMutPred2</td>
              <td rowspan="1" colspan="1">0.812</td>
              <td rowspan="1" colspan="1">0.657</td>
              <td rowspan="1" colspan="1">0.795</td>
              <td rowspan="1" colspan="1">0.906</td>
              <td rowspan="1" colspan="1">0.634</td>
              <td rowspan="1" colspan="1">0.344</td>
              <td rowspan="1" colspan="1">0.466</td>
              <td rowspan="1" colspan="1">0.761</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âLIST</td>
              <td rowspan="1" colspan="1">0.736</td>
              <td rowspan="1" colspan="1">0.495</td>
              <td rowspan="1" colspan="1">0.790</td>
              <td rowspan="1" colspan="1">0.904</td>
              <td rowspan="1" colspan="1">0.703</td>
              <td rowspan="1" colspan="1">0.437</td>
              <td rowspan="1" colspan="1">0.749</td>
              <td rowspan="1" colspan="1">0.809</td>
            </tr>
            <tr>
              <td colspan="9" rowspan="1">Predictors containing protein-/gene-level features</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âfathmm-W</td>
              <td rowspan="1" colspan="1">0.801</td>
              <td rowspan="1" colspan="1">0.615</td>
              <td rowspan="1" colspan="1">0.795</td>
              <td rowspan="1" colspan="1">0.889</td>
              <td rowspan="1" colspan="1">0.842</td>
              <td rowspan="1" colspan="1">0.686</td>
              <td rowspan="1" colspan="1">0.835</td>
              <td rowspan="1" colspan="1">0.898</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âPON-P2</td>
              <td rowspan="1" colspan="1">0.835</td>
              <td rowspan="1" colspan="1">0.670</td>
              <td rowspan="1" colspan="1">0.860</td>
              <td rowspan="1" colspan="1">0.929</td>
              <td rowspan="1" colspan="1">0.803</td>
              <td rowspan="1" colspan="1">0.614</td>
              <td rowspan="1" colspan="1">0.822</td>
              <td rowspan="1" colspan="1">0.896</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âREVEL</td>
              <td rowspan="1" colspan="1">0.825</td>
              <td rowspan="1" colspan="1">0.637</td>
              <td rowspan="1" colspan="1">0.701</td>
              <td rowspan="1" colspan="1">0.915</td>
              <td rowspan="1" colspan="1">0.744</td>
              <td rowspan="1" colspan="1">0.555</td>
              <td rowspan="1" colspan="1">0.662</td>
              <td rowspan="1" colspan="1">0.908</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âCADD</td>
              <td rowspan="1" colspan="1">0.725</td>
              <td rowspan="1" colspan="1">0.448</td>
              <td rowspan="1" colspan="1">0.672</td>
              <td rowspan="1" colspan="1">0.787</td>
              <td rowspan="1" colspan="1">0.675</td>
              <td rowspan="1" colspan="1">0.352</td>
              <td rowspan="1" colspan="1">0.658</td>
              <td rowspan="1" colspan="1">0.729</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âRF-based model</td>
              <td rowspan="1" colspan="1">0.857</td>
              <td rowspan="1" colspan="1">0.716</td>
              <td rowspan="1" colspan="1">0.861</td>
              <td rowspan="1" colspan="1">0.927</td>
              <td rowspan="1" colspan="1">
                <underline>0.858</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.718</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">0.853</td>
              <td rowspan="1" colspan="1">0.926</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âXGBoost-based model</td>
              <td rowspan="1" colspan="1">0.859</td>
              <td rowspan="1" colspan="1">0.719</td>
              <td rowspan="1" colspan="1">0.863</td>
              <td rowspan="1" colspan="1">
                <underline>0.934</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">0.856</td>
              <td rowspan="1" colspan="1">0.713</td>
              <td rowspan="1" colspan="1">0.854</td>
              <td rowspan="1" colspan="1">
                <underline>0.929</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">âLightGBM-based model</td>
              <td rowspan="1" colspan="1">
                <underline>0.868</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.737</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.872</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">0.931</td>
              <td rowspan="1" colspan="1">
                <underline>0.858</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.718</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.856</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
              <td rowspan="1" colspan="1">
                <underline>0.929</underline>
                <xref rid="tblfn3" ref-type="table-fn">
                  <sup>c</sup>
                </xref>
              </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tblfn1">
            <label>a</label>
            <p>Both PolyPhen2 and fathmm have two versions, so this table contains 16 lines for the 14 general-purpose predictors.</p>
          </fn>
          <fn id="tblfn2">
            <label>b</label>
            <p>No AUC was calculated for PhD-SNP due to lack of continuous prediction scores.</p>
          </fn>
          <fn id="tblfn3">
            <label>c</label>
            <p>The best value in each column is underlined.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>We are curious about whether the homologous relationship between proteins from the testing set and those from the training set have conferred overly optimistic performance. Hence, we removed the testing data whose proteins are homologous to those in the training set using the cd-hit webserver (<xref rid="btaa618-B20" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2020</xref>,<xref rid="btaa618-B21" ref-type="bibr">b</xref>) with 30% as cutoff. The datasets and the performance comparison before and after removing homologs (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables S4 and S5</xref>) demonstrate that the performance of our predictors remain similar, indicating that these homologous sequences in the testing dataset do not lead to overly optimistic results.</p>
      <p>The third-party dataset contains 2897 disease and 2897 neutral IDR nsSNVs, and the performance comparison on this dataset shows similar results (<xref rid="btaa618-T3" ref-type="table">TableÂ 3</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3</xref>). In detail, the best ACC (0.858), MCC (0.718), F1 score (0.856) and AUC (0.929) of our models have improved 1.6, 3.2, 2.1 and 2.1 percentage points, respectively, when compared to the best one in the other 13 predictors. The improvement of MCC is also the most significant in this comparison.</p>
      <p>It is worth noting that the independent testing dataset and the third-party dataset have no overlap with our training set. However, some of the testing nsSNVs may be in the training set of other predictors, which may not properly estimate their performance. For example, PMut2017 and PON-P2 used humsavar (October 2016 release) and VariBench for training, respectively (<xref rid="btaa618-B31" ref-type="bibr">Lopez-Ferrando <italic toggle="yes">et al.</italic>, 2017</xref>; <xref rid="btaa618-B40" ref-type="bibr">Niroula <italic toggle="yes">et al.</italic>, 2015</xref>). Therefore, the above comparisons may have underestimated the improved magnitude of our models. When a testing dataset having no overlap with any of the training datasets of all compared predictors is available, the improvement would hopefully be larger.</p>
      <p>Moreover, when comparing the performance of each predictor between the independent testing and the third-party dataset, our predictors are stable, while many others manifest large variance. All of these comparisons demonstrate that our IDR-specific models are robustly better in prioritizing pathogenic IDR nsSNVs from neutral ones than general predictors.</p>
      <p>As for the other three of the 17 general-purpose predictors, i.e. MetaSVM, MetaLR and M-CAP, our models also showed superior performance on the two testing datasets (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S6</xref>), with the only exception that the F1 score of M-CAP is slightly better. Because MetaSVM and MetaLR directly used allele frequency (AF) as a feature, and M-CAP adopted the prediction scores of MetaSVM/MetaLR as their features, we also supplemented ExAC-based AF to our optimal feature subset to re-train our models for the fair comparison with them.</p>
      <p>Another concern is how our models will perform on nsSNVs whose proteins contain both disease and neutral nsSNVs. To inspect this, from ToolScores datasets (<xref rid="btaa618-B18" ref-type="bibr">Grimm <italic toggle="yes">et al.</italic>, 2015</xref>) we removed nsSNVs that have occurred in the training data, and then selected proteins that contain both disease and neutral variants. After this filtering, we obtained a dataset with 2475 disease-associated and 873 neutral IDR nsSNVs from 321 proteins, and conducted an additional evaluation (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S7</xref>). Although the ACC and MCC have decreased, they are still high (though not ideal) with MCC greater than 0.61 and ACC greater than 0.84. Moreover, the performance of our models remains on the top tier, with other predictors dropping more. These results also demonstrated that predicting the disease-association of nsSNVs whose proteins have both disease and neutral variants are more challenging.</p>
    </sec>
    <sec>
      <title>3.4 Feature analysis</title>
      <p>To investigate relative contribution of the features in the optimal feature subset, we plotted the feature importance of each feature for the three models (<xref rid="btaa618-F2" ref-type="fig">Fig.Â 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). Although different models have no identical rank of relative feature importance, they provide some consensus insights: several alignment and gene-/protein-level features contribute more than others. The distributions of the standardized <italic toggle="yes">Z</italic>-scores of each feature in the disease and neutral group are shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S5</xref>. We inspect several representative features in detail here.
</p>
      <fig position="float" id="btaa618-F2">
        <label>Fig. 2.</label>
        <caption>
          <p>The feature importance based on RF. The importance is defined as the average gain of splits that use the feature in RF</p>
        </caption>
        <graphic xlink:href="btaa618f2" position="float"/>
      </fig>
      <p>Conservation features are one group of the most distinguishable features for predicting disease-associated nsSNVs (<xref rid="btaa618-B41" ref-type="bibr">Niroula and Vihinen, 2016</xref>). One may concern whether these features remain powerful in predicting disease nsSNVs in IDRs, as they are of lower sequence conservation (<xref rid="btaa618-B5" ref-type="bibr">Brown <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btaa618-B57" ref-type="bibr">Tang and Thomas, 2016b</xref>). Our results show that several conservation features were selected and ranked on top (<xref rid="btaa618-F2" ref-type="fig">Fig.Â 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). To inspect them further, we compared one of these features (the relative entropy based on the alignment with homologous non-human proteins in UniRef100, feature #9 in <xref rid="btaa618-T2" ref-type="table">TableÂ 2</xref>) between variants in IDRs and in ORs. The conservation levels in IDRs are indeed lower than in ORs (the lower the relative entropy, the higher the conservation level according to our definition in <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>), which is consistent with previous knowledge (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3A</xref>). Even though, the distributions of this feature are evidently distinguishable between disease and neutral nsSNVs, either in ORs or in IDRs. In OR nsSNVs, the feature medians of disease and neutral nsSNVs are 2.73 and 3.84, respectively (<italic toggle="yes">P</italic>-value: 0, MannâWhitney <italic toggle="yes">U</italic> test); in IDR nsSNVs, the medians are 2.85 and 4.56, accordingly (<italic toggle="yes">P</italic>-value: 0, MannâWhitney <italic toggle="yes">U</italic> test), showing even more evident separation in IDR nsSNVs (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3A</xref>). Hence, it is reasonable that the conservation or conservation-related features were selected.
</p>
      <fig position="float" id="btaa618-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>The boxplots of four features in IDR and OR nsSNVs. (<bold>A</bold>) The relative entropy at the nsSNV site. (<bold>B</bold>) The score estimating the probability that a gene is a recessive disease gene. (<bold>C</bold>) The hydrophobicity difference between the mutant and wild-type residue at the nsSNV site. (<bold>D</bold>) The SPOT-Disorder score of the wild-type residue at the nsSNV site</p>
        </caption>
        <graphic xlink:href="btaa618f3" position="float"/>
      </fig>
      <p>Certain protein-/gene-level annotations can prioritize disease genes and provide information for further prioritization of variants (<xref rid="btaa618-B25" ref-type="bibr">Itan <italic toggle="yes">et al.</italic>, 2015</xref>). Our work has selected four protein-/gene-level features, and all the three trained models ranked them within the top 10 (<xref rid="btaa618-F2" ref-type="fig">Fig.Â 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>). This observation hints that incorporation of gene-/protein-level features is beneficial in training predictors for disease nsSNVs. One of them is the score estimating the probability that a gene is a recessive disease gene (feature #11 in <xref rid="btaa618-T2" ref-type="table">TableÂ 2</xref>). This score has been widely used to discriminate Loss-of-Function tolerant genes (with low score) from recessive disease genes (with high score) (<xref rid="btaa618-B32" ref-type="bibr">MacArthur <italic toggle="yes">et al.</italic>, 2012</xref>). In our dataset, the feature values in the disease group are significantly higher than those in the neutral group (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3B</xref>), indicating that disease-related nsSNVs tend to come from recessive disease genes. The medians of disease and neutral nsSNVs are 0.417 and 0.121 in IDRs, respectively (<italic toggle="yes">P</italic>-value: 1.01E-59, MannâWhitney <italic toggle="yes">U</italic> test), while in OR these values are 0.333 and 0.152, respectively (<italic toggle="yes">P</italic>-value: 1.70E-70, MannâWhitney <italic toggle="yes">U</italic> test). Similar to the conservation, the separation of this feature between disease and neutral nsSNVs in IDRs is much larger than that in ORs, illustrating that it may have more potential in predicting disease nsSNVSs in IDRs than in ORs. As protein-/gene-level features cannot differentiate nsSNVs from the same protein, it is necessary to conduct cross-validation at the protein level in optimizing the hyperparameters of the prediction models (G10FCV in this work), and to perform additional evaluations on the dataset derived from proteins containing both disease and neutral variants (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S7</xref>).</p>
      <p>Hydrophobicity and disorder-related features have been demonstrated informative in developing general predictors (<xref rid="btaa618-B1" ref-type="bibr">Adzhubei <italic toggle="yes">et al.</italic>, 2010</xref>; <xref rid="btaa618-B20" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2010a</xref>; <xref rid="btaa618-B73" ref-type="bibr">Ye <italic toggle="yes">et al.</italic>, 2007</xref>). In this work, several selected features measure the sum of hydrophobicity propensity of a short peptide segment centered with the nsSNV site, i.e. hydrophobicity microenvironment, or the hydrophobicity differences between substituted residues. The disorder score of the wild-type residue at the nsSNV site has also been selected. Although their feature importance ranks are relatively low when compared to other types of features (<xref rid="btaa618-F2" ref-type="fig">Fig.Â 2</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4</xref>), their distributions between disease and neutral nsSNVs are still informative (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3C and D</xref>). For the hydrophobicity difference, the medians of disease and neutral nsSNVs are 0.18 and 0.05 in IDRs, respectively (<italic toggle="yes">P</italic>-value: 0.001, MannâWhitney <italic toggle="yes">U</italic> test); In ORs, these two values are 0.03 and 0.05 (<italic toggle="yes">P</italic>-value: 3.08E-7, MannâWhitney <italic toggle="yes">U</italic> test). The larger median of disease nsSNVs in IDRs may indicate that a larger portion of disease nsSNV have been substituted from hydrophilic to hydrophobic residues. Larger separation between disease and neutral nsSNVs in IDRs than in ORs can be observed as well.</p>
      <p>The disorder score and the DisProt annotation have been adopted to separate the IDRs from ORs in dataset curation, so the disorder scores of IDR nsSNVs are much larger than OR nsSNVs (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3D</xref>). Moreover, the medians of disease and neutral nsSNVs are 0.852 and 0.906 in IDRs, respectively (<italic toggle="yes">P</italic>-value: 6.84E-14, MannâWhitney <italic toggle="yes">U</italic> test), while these values are 0.041 and 0.061 in ORs (<italic toggle="yes">P</italic>-value: 0, MannâWhitney <italic toggle="yes">U</italic> test). The difference of medians between disease and neutral nsSNVs in IDRs is larger than that in ORs, which may also indicate that disorder scores have more potential to separate disease and neutral nsSNVs in IDRs than in ORs.</p>
    </sec>
    <sec>
      <title>3.5 The standalone package and web server</title>
      <p>Although the performance of the three models in our work is similar, we choose the LightGBM-based model as the default since it is much faster. The RF-based and XGBoost-based models are also provided as the options. The standalone package and the web server of our method, namely IDRMutPred, are freely available at <ext-link xlink:href="http://www.wdspdb.com/IDRMutPred" ext-link-type="uri">http://www.wdspdb.com/IDRMutPred</ext-link>. Anaconda was utilized to install all necessary packages and to share the running environment (<ext-link xlink:href="https://www.anaconda.com/" ext-link-type="uri">https://www.anaconda.com/</ext-link>), so the users can install and configure a local copy of IDRMutPred smoothly, which will be convenient for high throughput runs. The versions of the related Python packages are listed in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S8</xref>. In addition, a Docker image of the standalone IDRMutPred is also freely available at the website.</p>
      <p>IDRMutPred requires that the user should provide a protein sequence and a list of amino acid substitutions. The output contains the prediction score in the range between 0 and 1, and the binary classification is based on the default cutoff of 0.5. The users can further prioritize the disease-associated nsSNVs by ranking the scores.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>The better performance of IDRMutPred may roughly stem from several aspects. First, general predictors are âone-size-fits-allâ models based on training data from heterogeneous protein families or protein segments (<xref rid="btaa618-B51" ref-type="bibr">Riera <italic toggle="yes">et al.</italic>, 2014</xref>; <xref rid="btaa618-B66" ref-type="bibr">Vacic and Iakoucheva, 2012</xref>), while IDRMutPred has been trained on pure IDR nsSNVs, which are more homogeneous. It is reasonable to train better specific predictors on homogeneous datasets due to lower noise. Developing specific predictors has been practiced in several studies like KinMutRF, wKinMut-2, iFish and others (<xref rid="btaa618-B15" ref-type="bibr">Fechter and Porollo, 2014</xref>; <xref rid="btaa618-B26" ref-type="bibr">Izarzugaza <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btaa618-B47" ref-type="bibr">Pons <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btaa618-B69" ref-type="bibr">Vazquez <italic toggle="yes">et al.</italic>, 2016</xref>; <xref rid="btaa618-B70" ref-type="bibr">Wang and Wei, 2016</xref>).</p>
    <p>Second, homogeneous training data help to highlight informative features accordingly (<xref rid="btaa618-B62" ref-type="bibr">Torkamani and Schork, 2007</xref>). Intuitively, several features in our work have shown more evident contrast between disease and neutral nsSNVs in IDRs than in ORs, e.g. the relative entropy (<xref rid="btaa618-F3" ref-type="fig">Fig.Â 3A</xref>). If we combine the IDR with OR nsSNVs, the contrast between disease and neutral nsSNVs will be smaller, i.e. less informative. These features will contribute more in IDR nsSNVs predictors than in general ones, and will be supposed to result in the better performance of IDRMutPred.</p>
    <p>In summary, our work presents the first IDR nsSNV-specific predictor, IDRMutPred, which will hopefully serve as a valuable tool in the research community that focuses on the study of nsSNVs, especially those located in IDRs.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btaa618_Supplementary_Data</label>
      <media xlink:href="btaa618_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors would like to thank Dr. Xin-Hao Zhang and Fan Jiang for helpful suggestions. They also gratefully acknowledge the support of the National Supercomputer Center in Guangzhou (NSCC-GZ) for computing resources.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by the National Natural Science Foundation of China [31471243, 21933004, 30800641]; the Shenzhen Science and Technology Innovation Commission [JCYJ20170818085409785, JCYJ20170412150507046]; the Program for Guangdong Introducing Innovative and Entrepreneurial Talents; and the Shenzhen Municipal Health Commission [SZSM201809085].</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btaa618-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adzhubei</surname><given-names>I.A.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2010</year>) 
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat. Methods</source>, <volume>7</volume>, <fpage>248</fpage>â<lpage>249</lpage>.<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anderson</surname><given-names>A.C.</given-names></string-name></person-group> (<year>2003</year>) 
<article-title>The process of structure-based drug design</article-title>. <source>Chem. Biol</source>., <volume>10</volume>, <fpage>787</fpage>â<lpage>797</lpage>.<pub-id pub-id-type="pmid">14522049</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Babu</surname><given-names>M.M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2012</year>) 
<article-title>Versatility from protein disorder</article-title>. <source>Science</source>, <volume>337</volume>, <fpage>1460</fpage>â<lpage>1461</lpage>.<pub-id pub-id-type="pmid">22997313</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Breiman</surname><given-names>L.</given-names></string-name></person-group> (<year>2001</year>) 
<article-title>Random forests</article-title>. <source>Mach. Learn</source>., <volume>45</volume>, <fpage>5</fpage>â<lpage>32</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brown</surname><given-names>C.J.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2011</year>) 
<article-title>Evolution and disorder</article-title>. <source>Curr. Opin. Struct. Biol</source>., <volume>21</volume>, <fpage>441</fpage>â<lpage>446</lpage>.<pub-id pub-id-type="pmid">21482101</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Capriotti</surname><given-names>E.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2006</year>) 
<article-title>Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information</article-title>. <source>Bioinformatics</source>, <volume>22</volume>, <fpage>2729</fpage>â<lpage>2734</lpage>.<pub-id pub-id-type="pmid">16895930</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B7">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>T.</given-names></string-name>, <string-name><surname>Guestrin</surname><given-names>C.</given-names></string-name></person-group> (<year>2016</year>) XGBoost: a scalable tree boosting system. In <italic toggle="yes">Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining</italic>, San Francisco, CA, USA. ACM, pp. <fpage>785</fpage>â<lpage>794</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>Y.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2006</year>) 
<article-title>Abundance of intrinsic disorder in protein associated with cardiovascular disease</article-title>. <source>Biochemistry</source>, <volume>45</volume>, <fpage>10448</fpage>â<lpage>10460</lpage>.<pub-id pub-id-type="pmid">16939197</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Choi</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chan</surname><given-names>A.P.</given-names></string-name></person-group> (<year>2015</year>) 
<article-title>PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels</article-title>. <source>Bioinformatics</source>, <volume>31</volume>, <fpage>2745</fpage>â<lpage>2747</lpage>.<pub-id pub-id-type="pmid">25851949</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cooper</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Shendure</surname><given-names>J.</given-names></string-name></person-group> (<year>2011</year>) 
<article-title>Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data</article-title>. <source>Nat. Rev. Genet</source>., <volume>12</volume>, <fpage>628</fpage>â<lpage>640</lpage>.<pub-id pub-id-type="pmid">21850043</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>C.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2015</year>) 
<article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source>Hum. Mol. Genet</source>., <volume>24</volume>, <fpage>2125</fpage>â<lpage>2137</lpage>.<pub-id pub-id-type="pmid">25552646</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drotar</surname><given-names>P.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2015</year>) 
<article-title>An experimental comparison of feature selection methods on two-class biomedical datasets</article-title>. <source>Comput. Biol. Med</source>., <volume>66</volume>, <fpage>1</fpage>â<lpage>10</lpage>.<pub-id pub-id-type="pmid">26327447</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edsall</surname><given-names>J.T.</given-names></string-name></person-group> (<year>1995</year>) 
<article-title>Hsien Wu and the first theory of protein denaturation (1931)</article-title>. <source>Adv. Protein Chem</source>., <volume>46</volume>, <fpage>1</fpage>â<lpage>5</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eisenberg</surname><given-names>D.</given-names></string-name>, <string-name><surname>McLachlan</surname><given-names>A.D.</given-names></string-name></person-group> (<year>1986</year>) 
<article-title>Solvation energy in protein folding and binding</article-title>. <source>Nature</source>, <volume>319</volume>, <fpage>199</fpage>â<lpage>203</lpage>.<pub-id pub-id-type="pmid">3945310</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fechter</surname><given-names>K.</given-names></string-name>, <string-name><surname>Porollo</surname><given-names>A.</given-names></string-name></person-group> (<year>2014</year>) 
<article-title>MutaCYP: classification of missense mutations in human cytochromes P450</article-title>. <source>BMC Med. Genomics</source>, <volume>7</volume>, <fpage>47</fpage>.<pub-id pub-id-type="pmid">25073475</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Georgi</surname><given-names>B.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2013</year>) 
<article-title>From mouse to human: evolutionary genomics analysis of human orthologs of essential genes</article-title>. <source>PLoS Genet</source>., <volume>9</volume>, <fpage>e1003484</fpage>.<pub-id pub-id-type="pmid">23675308</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Goodwin</surname><given-names>S.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>Coming of age: ten years of next-generation sequencing technologies</article-title>. <source>Nat. Rev. Genet</source>., <volume>17</volume>, <fpage>333</fpage>â<lpage>351</lpage>.<pub-id pub-id-type="pmid">27184599</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grimm</surname><given-names>D.G.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2015</year>) 
<article-title>The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity</article-title>. <source>Hum. Mutat</source>., <volume>36</volume>, <fpage>513</fpage>â<lpage>523</lpage>.<pub-id pub-id-type="pmid">25684150</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hanson</surname><given-names>J.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>Improving protein disorder prediction by deep bidirectional long short-term memory recurrent neural networks</article-title>. <source>Bioinformatics</source>, <volume>33</volume>, <fpage>685</fpage>â<lpage>692</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>T.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2010</year>a) 
<article-title>Prediction of deleterious non-synonymous SNPs based on protein interaction network and hybrid properties</article-title>. <source>PLoS One</source>, <volume>5</volume>, <fpage>e11900</fpage>.<pub-id pub-id-type="pmid">20689580</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>Y.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2010</year>b) 
<article-title>CD-HIT Suite: a web server for clustering and comparing biological sequences</article-title>. <source>Bioinformatics</source>, <volume>26</volume>, <fpage>680</fpage>â<lpage>682</lpage>.<pub-id pub-id-type="pmid">20053844</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iakoucheva</surname><given-names>L.M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2002</year>) 
<article-title>Intrinsic disorder in cell-signaling and cancer-associated proteins</article-title>. <source>J. Mol. Biol</source>., <volume>323</volume>, <fpage>573</fpage>â<lpage>584</lpage>.<pub-id pub-id-type="pmid">12381310</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ioannidis</surname><given-names>N.M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>REVEL: an ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source>Am. J. Hum. Genet</source>., <volume>99</volume>, <fpage>877</fpage>â<lpage>885</lpage>.<pub-id pub-id-type="pmid">27666373</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ionita-Laza</surname><given-names>I.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>A spectral approach integrating functional genomic annotations for coding and noncoding variants</article-title>. <source>Nat. Genet</source>., <volume>48</volume>, <fpage>214</fpage>â<lpage>220</lpage>.<pub-id pub-id-type="pmid">26727659</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Itan</surname><given-names>Y.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2015</year>) 
<article-title>The human gene damage index as a gene-level approach to prioritizing exome variants</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>112</volume>, <fpage>13615</fpage>â<lpage>13620</lpage>.<pub-id pub-id-type="pmid">26483451</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Izarzugaza</surname><given-names>J.M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2012</year>) 
<article-title>Prioritization of pathogenic mutations in the protein kinase superfamily</article-title>. <source>BMC Genomics</source>, <volume>13</volume>, <fpage>S3</fpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jagadeesh</surname><given-names>K.A.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity</article-title>. <source>Nat. Genet</source>., <volume>48</volume>, <fpage>1581</fpage>â<lpage>1586</lpage>.<pub-id pub-id-type="pmid">27776117</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ke</surname><given-names>G.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2017</year>) 
<article-title>LightGBM: a highly efficient gradient boosting decision tree</article-title>. <source>Adv. Neural Inf. Process. Syst</source>., <volume>30</volume>, <fpage>30</fpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lise</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname><given-names>D.</given-names></string-name></person-group> (<year>2004</year>) 
<article-title>Sequence patterns associated with disordered regions in proteins</article-title>. <source>Proteins Struct. Funct. Bioinf</source>., <volume>58</volume>, <fpage>144</fpage>â<lpage>150</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>X.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>dbNSFP v3. 0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs</article-title>. <source>Hum. Mutat</source>., <volume>37</volume>, <fpage>235</fpage>â<lpage>241</lpage>.<pub-id pub-id-type="pmid">26555599</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lopez-Ferrando</surname><given-names>V.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2017</year>) 
<article-title>PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>W222</fpage>â<lpage>W228</lpage>.<pub-id pub-id-type="pmid">28453649</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacArthur</surname><given-names>D.G.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2012</year>) 
<article-title>A systematic survey of loss-of-function variants in human protein-coding genes</article-title>. <source>Science</source>, <volume>335</volume>, <fpage>823</fpage>â<lpage>828</lpage>.<pub-id pub-id-type="pmid">22344438</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Malhis</surname><given-names>N.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2019</year>) 
<article-title>Improved measures for evolutionary conservation that exploit taxonomy distances</article-title>. <source>Nat. Commun</source>., <volume>10</volume>, <fpage>1556</fpage>.<pub-id pub-id-type="pmid">30952844</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marengo-Rowe</surname><given-names>A.J.</given-names></string-name></person-group> (<year>2006</year>) 
<article-title>Structure-function relations of human hemoglobins</article-title>. <source>Proc. (Bayl. Univ. Med. Cent.)</source>, <volume>19</volume>, <fpage>239</fpage>â<lpage>245</lpage>.<pub-id pub-id-type="pmid">17252042</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mark</surname><given-names>W.-Y.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2005</year>) 
<article-title>Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple proteinâprotein and proteinâDNA interactions?</article-title> Â <source>J. Mol. Biol</source>., <volume>345</volume>, <fpage>275</fpage>â<lpage>287</lpage>.<pub-id pub-id-type="pmid">15571721</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meyer</surname><given-names>K.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2018</year>) 
<article-title>Mutations in disordered regions can cause disease by creating dileucine motifs</article-title>. <source>Cell</source>, <volume>175</volume>, <fpage>239</fpage>â<lpage>253</lpage>.<pub-id pub-id-type="pmid">30197081</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mort</surname><given-names>M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2010</year>) 
<article-title>In silico functional profiling of human disease-associated and polymorphic amino acid substitutions</article-title>. <source>Hum. Mutat</source>., <volume>31</volume>, <fpage>335</fpage>â<lpage>346</lpage>.<pub-id pub-id-type="pmid">20052762</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nair</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Vihinen</surname><given-names>M.</given-names></string-name></person-group> (<year>2013</year>) 
<article-title>VariBench: a benchmark database for variations</article-title>. <source>Hum. Mutat</source>., <volume>34</volume>, <fpage>42</fpage>â<lpage>49</lpage>.<pub-id pub-id-type="pmid">22903802</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ng</surname><given-names>P.C.</given-names></string-name>, <string-name><surname>Henikoff</surname><given-names>S.</given-names></string-name></person-group> (<year>2001</year>) 
<article-title>Predicting deleterious amino acid substitutions</article-title>. <source>Genome Res</source>., <volume>11</volume>, <fpage>863</fpage>â<lpage>874</lpage>.<pub-id pub-id-type="pmid">11337480</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Niroula</surname><given-names>A.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2015</year>) 
<article-title>PON-P2: prediction method for fast and reliable identification of harmful variants</article-title>. <source>PLoS One</source>, <volume>10</volume>, <fpage>e0117380</fpage>.<pub-id pub-id-type="pmid">25647319</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Niroula</surname><given-names>A.</given-names></string-name>, <string-name><surname>Vihinen</surname><given-names>M.</given-names></string-name></person-group> (<year>2016</year>) 
<article-title>Variation interpretation predictors: principles, types, performance, and choice</article-title>. <source>Hum. Mutat</source>., <volume>37</volume>, <fpage>579</fpage>â<lpage>597</lpage>.<pub-id pub-id-type="pmid">26987456</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pedregosa</surname><given-names>F.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2011</year>) 
<article-title>Scikit-learn: machine learning in Python</article-title>. <source>J. Mach. Learn. Res</source>., <volume>12</volume>, <fpage>2825</fpage>â<lpage>2830</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B43">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Pejaver</surname><given-names>V.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2017</year>) MutPred2: inferring the molecular and phenotypic impact of amino acid variants. <pub-id pub-id-type="doi">10.1101/134981</pub-id>.</mixed-citation>
    </ref>
    <ref id="btaa618-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pentony</surname><given-names>M.M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2010</year>) 
<article-title>Computational resources for the prediction and analysis of native disorder in proteins</article-title>. <source>Methods Mol. Biol. (Clifton, N.J.)</source>, <volume>604</volume>, <fpage>369</fpage>â<lpage>393</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petrovski</surname><given-names>S.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2013</year>) 
<article-title>Genic intolerance to functional variation and the interpretation of personal genomes</article-title>. <source>PLoS Genet</source>., <volume>9</volume>, <fpage>e1003709</fpage>.<pub-id pub-id-type="pmid">23990802</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Piovesan</surname><given-names>D.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2017</year>) 
<article-title>DisProt 7.0: a major update of the database of disordered proteins</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D219</fpage>â<lpage>D227</lpage>.<pub-id pub-id-type="pmid">27899601</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pons</surname><given-names>T.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>KinMutRF: a random forest classifier of sequence variants in the human protein kinase superfamily</article-title>. <source>BMC Genomics</source>, <volume>17</volume>, <fpage>396</fpage>.<pub-id pub-id-type="pmid">27357839</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Raychaudhuri</surname><given-names>S.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2009</year>) 
<article-title>The role of intrinsically unstructured proteins in neurodegenerative diseases</article-title>. <source>PLoS One</source>, <volume>4</volume>, <fpage>e5566</fpage>.<pub-id pub-id-type="pmid">19440375</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rentzsch</surname><given-names>P.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2019</year>) 
<article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D886</fpage>â<lpage>D894</lpage>.<pub-id pub-id-type="pmid">30371827</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B50">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reva</surname><given-names>B.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2011</year>) 
<article-title>Predicting the functional impact of protein mutations: application to cancer genomics</article-title>. <source>Nucleic Acids Res</source>., <volume>39</volume>, <fpage>e118</fpage>.<pub-id pub-id-type="pmid">21727090</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Riera</surname><given-names>C.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2014</year>) 
<article-title>Prediction of pathological mutations in proteins: the challenge of integrating sequence conservation and structure stability principles</article-title>. <source>Wiley Interdiscip. Rev. Comput. Mol. Sci</source>., <volume>4</volume>, <fpage>249</fpage>â<lpage>268</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B52">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Romero</surname><given-names>P.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2001</year>) 
<article-title>Sequence complexity of disordered protein</article-title>. <source>Proteins Struct. Funct. Bioinf</source>., <volume>42</volume>, <fpage>38</fpage>â<lpage>48</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ruan</surname><given-names>H.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2019</year>) 
<article-title>Targeting intrinsically disordered proteins at the edge of chaos</article-title>. <source>Drug Disc. Today</source>, <volume>24</volume>, <fpage>217</fpage>â<lpage>227</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa618-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schmeing</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Ramakrishnan</surname><given-names>V.</given-names></string-name></person-group> (<year>2009</year>) 
<article-title>What recent ribosome structures have revealed about the mechanism of translation</article-title>. <source>Nature</source>, <volume>461</volume>, <fpage>1234</fpage>â<lpage>1242</lpage>.<pub-id pub-id-type="pmid">19838167</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shihab</surname><given-names>H.A.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2013</year>) 
<article-title>Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models</article-title>. <source>Hum. Mutat</source>., <volume>34</volume>, <fpage>57</fpage>â<lpage>65</lpage>.<pub-id pub-id-type="pmid">23033316</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stefl</surname><given-names>S.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2013</year>) 
<article-title>Molecular mechanisms of disease-causing missense mutations</article-title>. <source>J. Mol. Biol</source>., <volume>425</volume>, <fpage>3919</fpage>â<lpage>3936</lpage>.<pub-id pub-id-type="pmid">23871686</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.D.</given-names></string-name></person-group> (<year>2016</year>a) 
<article-title>PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation</article-title>. <source>Bioinformatics</source>, <volume>32</volume>, <fpage>2230</fpage>â<lpage>2232</lpage>.<pub-id pub-id-type="pmid">27193693</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Thomas</surname><given-names>P.D.</given-names></string-name></person-group> (<year>2016</year>b) 
<article-title>Tools for predicting the functional impact of nonsynonymous genetic variation</article-title>. <source>Genetics</source>, <volume>203</volume>, <fpage>635</fpage>â<lpage>647</lpage>.<pub-id pub-id-type="pmid">27270698</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B59">
      <mixed-citation publication-type="journal">The UniProt Consortium. (<year>2019</year>) 
<article-title>UniProt: a worldwide hub of protein knowledge</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D506</fpage>â<lpage>D515</lpage>.<pub-id pub-id-type="pmid">30395287</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tompa</surname><given-names>P.</given-names></string-name></person-group> (<year>2002</year>) 
<article-title>Intrinsically unstructured proteins</article-title>. <source>Trends Biochem. Sci</source>., <volume>27</volume>, <fpage>527</fpage>â<lpage>533</lpage>.<pub-id pub-id-type="pmid">12368089</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tompa</surname><given-names>P.</given-names></string-name></person-group> (<year>2005</year>) 
<article-title>The interplay between structure and function in intrinsically unstructured proteins</article-title>. <source>FEBS Lett</source>., <volume>579</volume>, <fpage>3346</fpage>â<lpage>3354</lpage>.<pub-id pub-id-type="pmid">15943980</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Torkamani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schork</surname><given-names>N.J.</given-names></string-name></person-group> (<year>2007</year>) 
<article-title>Accurate prediction of deleterious protein kinase polymorphisms</article-title>. <source>Bioinformatics</source>, <volume>23</volume>, <fpage>2918</fpage>â<lpage>2925</lpage>.<pub-id pub-id-type="pmid">17855419</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uversky</surname><given-names>V.N.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2014</year>) 
<article-title>Pathological unfoldomics of uncontrolled chaos: intrinsically disordered proteins and human diseases</article-title>. <source>Chem. Rev</source>., <volume>114</volume>, <fpage>6844</fpage>â<lpage>6879</lpage>.<pub-id pub-id-type="pmid">24830552</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uversky</surname><given-names>V.N.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2000</year>) 
<article-title>Why are ânatively unfoldedâ proteins unstructured under physiologic conditions?</article-title> Â <source>Proteins Struct. Funct. Genet</source>., <volume>41</volume>, <fpage>415</fpage>â<lpage>427</lpage>.<pub-id pub-id-type="pmid">11025552</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Uversky</surname><given-names>V.N.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2008</year>) 
<article-title>Intrinsically disordered proteins in human diseases: introducing the D2 concept</article-title>. <source>Annu. Rev. Biophys</source>., <volume>37</volume>, <fpage>215</fpage>â<lpage>246</lpage>.<pub-id pub-id-type="pmid">18573080</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B66">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vacic</surname><given-names>V.</given-names></string-name>, <string-name><surname>Iakoucheva</surname><given-names>L.M.</given-names></string-name></person-group> (<year>2012</year>) 
<article-title>Disease mutations in disordered regionsâexception to the rule?</article-title> Â <source>Mol. Biosyst</source>., <volume>8</volume>, <fpage>27</fpage>â<lpage>32</lpage>.<pub-id pub-id-type="pmid">22080206</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B67">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vacic</surname><given-names>V.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2012</year>) 
<article-title>Disease-associated mutations disrupt functionally important regions of intrinsic protein disorder</article-title>. <source>PLoS Comput. Biol</source>., <volume>8</volume>, <fpage>e1002709</fpage>.<pub-id pub-id-type="pmid">23055912</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B68">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Der Lee</surname><given-names>R.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2014</year>) 
<article-title>Classification of intrinsically disordered regions and proteins</article-title>. <source>Chem. Rev</source>., <volume>114</volume>, <fpage>6589</fpage>â<lpage>6631</lpage>.<pub-id pub-id-type="pmid">24773235</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B69">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vazquez</surname><given-names>M.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2016</year>) 
<article-title>wKinMut-2: identification and interpretation of pathogenic variants in human protein kinases</article-title>. <source>Hum. Mutat</source>., <volume>37</volume>, <fpage>36</fpage>â<lpage>42</lpage>.<pub-id pub-id-type="pmid">26443060</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B70">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Wei</surname><given-names>L.</given-names></string-name></person-group> (<year>2016</year>) 
<article-title>iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers</article-title>. <source>Sci. Rep</source>., <volume>6</volume>, <fpage>31321</fpage>.<pub-id pub-id-type="pmid">27527004</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B71">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ward</surname><given-names>J.J.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2004</year>) 
<article-title>Prediction and functional analysis of native disorder in proteins from the three kingdoms of life</article-title>. <source>J. Mol. Biol</source>., <volume>337</volume>, <fpage>635</fpage>â<lpage>645</lpage>.<pub-id pub-id-type="pmid">15019783</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B72">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wimley</surname><given-names>W.C.</given-names></string-name>, <string-name><surname>White</surname><given-names>S.H.</given-names></string-name></person-group> (<year>1996</year>) 
<article-title>Experimentally determined hydrophobicity scale for proteins at membrane interfaces</article-title>. <source>Nat. Struct. Biol</source>., <volume>3</volume>, <fpage>842</fpage>â<lpage>848</lpage>.<pub-id pub-id-type="pmid">8836100</pub-id></mixed-citation>
    </ref>
    <ref id="btaa618-B73">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>Z.Q.</given-names></string-name></person-group> Â <etal>et al</etal> (<year>2007</year>) 
<article-title>Finding new structural and sequence attributes to predict possible disease association of single amino acid polymorphism (SAP)</article-title>. <source>Bioinformatics</source>, <volume>23</volume>, <fpage>1444</fpage>â<lpage>1450</lpage>.<pub-id pub-id-type="pmid">17384424</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
